R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

Cited by (1,000)

Items 701–800 of 1,000

  1. Promotion of the resistance of human oral epithelial cells to herpes simplex virus type I infection via N6-methyladenosine modification
    Junping Xu, Yuping Qi, Qi Ju · 2023 · BMC Oral Health
  2. The lncRNA DAMER selectively guides m6A-dependent regulation of ATF4 and asparagine metabolism under nutrient stress in cancer
    Tianyu Tao, Xianming Feng, Yi Yang, Bangdong Liu, Jiaer Liang, Zishuo Chen, Shuqi Wang, Jiaqi Zhao, Xiuxiu Yang, Liyun Huo et al. · 2026 · Nature Cell Biology
  3. Metabolic turnover and dynamics of modified ribonucleosides by 13C labeling
    Gameiro, Paulo A., Encheva, Vesela, Dos Santos, Mariana Silva, MacRae, James I., Ule, Jernej · 2021 · Journal of Biological Chemistry
  4. Induction of functional neutrophils from mouse fibroblasts by thymidine through enhancement of Tet3 activity
    Buqing Ye, Liuliu Yang, Benyu Liu, Nian Liu, Dongdong Fan, Huimu Li, Lei Sun, Ying Du, Shuo Wang, Yong Tian et al. · 2022 · Cellular and Molecular Immunology
  5. FTO Stabilizes MIS12 to Inhibit Vascular Smooth Muscle Cell Senescence in Atherosclerotic Plaque
    Jingzhao Sun, Mengqi Wang, Fengming Jia, Jiantao Song, Jinlin Ren, Bo Hu · 2024 · Journal of Inflammation Research
  6. Role of m6A modifications in immune evasion and immunotherapy
    Chunyu Wu, Lvyuan Li, Qiling Tang, Qianjin Liao, Pan Chen, Can Guo, Zhaoyang Zeng, Wei Xiong · 2024 · Medical Oncology
  7. Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitors
    Changyu Ren, Zhi Wei Cao, Yang Liu, Rui Wang, Congcong Lin, Zishu Wang · 2024 · Future Medicinal Chemistry
  8. Methyltransferase‐Like 3–Mediated N6‐Methyladenosine RNA Methylation Regulates Hypoxia‐Induced Pulmonary Arterial Smooth Muscle Cell Pyroptosis by Targeting PTEN
    Yuan Jiang, Huiyu Liu, Ruimin Shi, Yingying Hao, Junting Zhang, Wei Xin, Yiying Li, Cui Ma, Xiaodong Zheng, Lixin Zhang et al. · 2024 · Journal of the American Heart Association
  9. RNA modification regulators as promising biomarkers in gynecological cancers
    Yue Qi, Tian Xiang Li, Yang Zhou, Yingying Hao, Jin Zhang · 2024 · Cell Biology and Toxicology
  10. Erythrocyte-Based Biomimetic MOFs as a Triple Epigenetic Regulator for Enhancing Anti-Leukemia Immunity
    Min Ding, Xinlun Dai, Chunfeng Yang, Zhen Zhang, Zhihua Wang, Yiqiao Wang, Yumei Li, Fei Yan · 2024 · Nano Letters
  11. Regulation and application of m6A modification in tumor immunity
    Qunli Xiong, Yaguang Zhang, Ying Zheng, Qing Zhu · 2024 · Science China Life Sciences
  12. FTO effects the proliferation, invasion, and glycolytic metabolism of colon cancer by regulating PKM2
    Kongyan Zhang, Fei Zhang, Jiahe Wang · 2025 · Journal of Cancer Research and Clinical Oncology
  13. FTO suppresses DNA repair by inhibiting PARP1
    Tianyi Zhu, Jing Zhi Anson Tan, Lingrui Zhang, He Huang, Sooraj Siva Das, Flora Cheng, Pranesh Padmanabhan, Mathew V. Jones, Mihwa Lee, Albert Lee et al. · 2025 · Nature Communications
  14. FTO‐mediated m6A demethylation regulates IGFBP3 expression and AKT activation through IMP3‐dependent P‐body re‐localisation in lung cancer
    Haiyang Wang, Hui Peng, Zhenzhen Zhang, Yilimunuer Abulimiti, Jiayi Hu, Yongxin Zhou, Ping Ji, Dong Li · 2025 · Clinical and Translational Medicine
  15. Role of m⁶A RNA Methylation in Mediating Resistance to Chemotherapy and Immunotherapy in Cancer
    Olli Johannes Laaksonen, Mikko Petteri Virtanen · 2025 · Archive of International Journal of Cancer and Allied Science
  16. Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N6-Methyladenosine RNA Methylation Regulators
    Yan Zhang, Yao Yao, Xiaochen Qi, Jianyi Li, Meihong Liu, Xiangyu Che, Yingkun Xu, Guangzhen Wu · 2021 · Journal of Immunology Research
  17. The role of RNA modification in the generation of acquired drug resistance in glioma
    Yu Yan, Wei Wei, Shengrong Long, Shengda Ye, Bin Yang, Jiazhi Jiang, Xiang Li, Jincao Chen · 2022 · Frontiers in Genetics
  18. FTO regulates the DNA damage response via effects on cell-cycle progression
    Weiying Liu, Manabu Yasui, Akira Sassa, Xinyue You, Jingjing Wan, Yiyi Cao, Jing Xi, Xinyu Zhang, Masamitsu Honma, Yang Luan · 2023 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
  19. An RNA Methylation-Sensitive AIEgen-Aptamer Reporting System for Quantitatively Evaluating m6A Methylase and Demethylase Activities
    Xiner Ying, Chenyang Huang, Tengwei Li, Ting Li, Minsong Gao, Fengqin Wang, Jie Cao, Jianzhao Liu · 2023 · ACS Chemical Biology
  20. Clinical Perspectives in Epitranscriptomics
    Eloy Santos-Pujol, Carlos Quero-Dotor, Manel Esteller · 2024 · Current Opinion in Genetics & Development
  21. A chromatin perspective on metabolic and genotoxic impacts on hematopoietic stem and progenitor cells
    Zhenhua Yang, Hao Jiang · 2020 · Cellular and Molecular Life Sciences
  22. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
    Chengquan Shen, Jing Liu, Xiaokun Yang, Wei Jiao, Yonghua Wang · 2021 · Frontiers in Endocrinology
  23. Identification of tectoridin as the inhibitor of FTO by isothermal titration calorimetric and spectroscopic methods
    Xitong Li, Shuting Gao, Ning Zhang, Miao Zhang, Ruiyong Wang, Junbiao Chang · 2021 · New Journal of Chemistry
  24. Comprehensive analysis of m6A regulator-based methylation modification patterns characterized by distinct immune profiles in colon adenocarcinomas
    Tao Liu, Huhu Li, Gang Du, Jun Ma, Junpeng Shen, Haoliang Zhao, Fei Luo, Huiyu Li · 2022 · Gene
  25. Why novel mRNA modifications are so challenging and what we can do about it
    Audrey Penning, Jana Jeschke, François Fuks · 2022 · Nature Reviews Molecular Cell Biology
  26. Correlation between RNA N6-methyladenosine and ferroptosis in cancer: current status and prospects
    Qianzi Liu, Linxi Lv, Xueding Cai, Jiandong Zhu, Jifa Li, Lehe Yang, Xiaona Xie, Chengguang Zhao, Haiyang Zhao · 2024 · Frontiers in Cell and Developmental Biology
  27. The metabolic baton: conducting the dance of N6-methyladenosine writing and erasing
    Robert J. Rabelo-Fernández, Madeline Yuen, Pedro J. Batista · 2024 · Current Opinion in Genetics & Development
  28. DNA damage-mediated FTO downregulation promotes CRPC progression by inhibiting FOXO3a via an m6A-dependent mechanism
    Lele Xu, Yuting Chen, Tao Wu, Jiaqi Fan, Yuying Hu, Xuefeng Gao, Yuliang Wang, Tao Chen, Xueting Zhao, Min Zeng et al. · 2024 · iScience
  29. Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance
    Enol Álvarez-González, Luisa María Sierra · 2024 · International Journal of Molecular Sciences
  30. Dysregulation of pseudouridylation in small RNAs contributes to papillary thyroid carcinoma metastasis
    Xi Wang, Hengyuan Gao, Wenjun Pu, Zhipeng Zeng, Nan Lan Xu, Xunpeng Luo, Donge Tang, Yong Dai · 2024 · Cancer Cell International
  31. N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment
    Xiaoyue Li, Lin Peng, Xuelian Yang, Jing Luo, Jianmei Wang, Kelin Mou, Huan Zhou, Yuhao Luo, Xiang Li · 2024 · Frontiers in Immunology
  32. Cold atmospheric plasma control metabolic syndromes via targeting fat mass and obesity-associated protein
    Xiaofeng Dai, Shuo Feng, Tian Xiang Li · 2025 · Pharmacological Research
  33. Targeting RNA adenosine editing and modification enzymes for RNA therapeutics
    Nikolaos I. Vlachogiannis, Maria Polycarpou‐Schwarz, Aikaterini-Paraskevi Avdi, Simon Tual‐Chalot, Konstantinos Stellos · 2025 · Molecular Therapy
  34. The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5
    Man Zhao, Dalin Zhang, Haowen Jiang, Nishanth Kuganesan, Suchitra Natarajan, Leighton Pu, Kaushik N. Thakkar, Hongjuan Zhao, Quynh‐Thu Le, Amato J. Giaccia et al. · 2025 · Science Advances
  35. RNA modifications in health and disease: from mechanistic insights to therapeutic applications
    Yiting Chen, Dulin Ding, Xing Tang, Rui Ma, Jiankang Zhou · 2025 · Precision Clinical Medicine
  36. Epitranscriptomic modifications in acute myeloid leukemia: m6A and 2′-O-methylation as targets for novel therapeutic strategies
    Cornelius Pauli, Michael Kienhöfer, Stefanie Göllner, Carsten Müller‐Tidow · 2021 · Biological Chemistry
  37. From viability to cell death: Claims with insufficient evidence in high-impact cell culture studies
    Ali Burak Özkaya, Caner Geyik · 2022 · PLoS ONE
  38. The crucial roles of m6A RNA modifications in cutaneous cancers: Implications in pathogenesis, metastasis, drug resistance, and targeted therapies
    Cong Huang, Kaoyuan Zhang, Yang Guo, Changbing Shen, Xiaoming Liu, Haiyan Huang, Xia Dou, Bo Yu · 2022 · Genes & Diseases
  39. Prognostic Characteristics and Immune Effects of N6-Methyladenosine and 5-Methylcytosine-Related Regulatory Factors in Clear Cell Renal Cell Carcinoma
    Lei Li, Zijia Tao, Yiqiao Zhao, Mingyang Li, Jianyi Zheng, Zeyu Li, Xiaonan Chen · 2022 · Frontiers in Genetics
  40. The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine
    Zhuoyu Xiao, Sun Liu, Zengguang Li, J. Jean Cui, Hailan Wang, Zihan Wang, Qihuan Ren, Laixin Xia, Zhijian Wang, Yuan Li · 2022 · Frontiers in Cell and Developmental Biology
  41. Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma
    Yaohai Wu, Shiqiang Zhang, Chujie Chen, Jun Pang · 2022 · Current Urology
  42. RNA m6A methylation regulators in endometrial cancer (Review)
    Siyi Shen, Jialu Guo, Nengyuan Lv, Qianying Chen, Jinyi Tong · 2022 · International Journal of Oncology
  43. N6-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
    Xin Zheng, Shenggang Li, Ju Yu, Chungang Dai, Suji Yan, Gang Chen, Chao Sun · 2023 · Translational Cancer Research
  44. The emerging role of N6-methyladenine RNA methylation in metal ion metabolism and metal-induced carcinogenesis
    Yaxu Liang, Huan Wang, Bencheng Wu, Ning Peng, Dongming Yu, Xin Wu, Xiang Zhong · 2023 · Environmental Pollution
  45. EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A
    Shaohai Wang, Lin Liu, Ke-yong Bao, Yifan Zhang, Wen-wen Wang, Du Shi, Na-er Jia, Suo Suo, Jing Cai, Jianfeng Guo et al. · 2023 · Current Medical Science
  46. Bioinformatic analysis of m6A “reader” YTH family in pan-cancer as a clinical prognosis biomarker
    Lin Li, Chao Tang, Jianqing Ye, Da Xu, Chuanmin Chu, Lei Wang, Qiwei Zhou, Sishun Gan, Bing Liu · 2023 · Scientific Reports
  47. Non‐m6A RNA modifications in haematological malignancies
    Meiling Chen, Yuanzhong Chen, Kitty Wang, Xiaolan Deng, Jianjun Chen · 2024 · Clinical and Translational Medicine
  48. IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment
    Patricia D.B. Tiburcio, Bing Xiao, Yi Chai, Sydney Asper, Sheryl R. Tripp, David L. Gillespie, Randy L. Jensen, Eric L. Huang · 2018 · Oncotarget
  49. New prognostic factors and scoring system for patients with acute myeloid leukemia
    Ye Kuang, Yang Wang, Xianghong Cao, Chuanmei Peng, Hui Gao · 2021 · Oncology Letters
  50. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma
    Zhen-Dong Huang, Lulu Lin, Zizhen Liu, Chao Hu, Hui-Yun Gu, Renxiong Wei · 2021 · Frontiers in Immunology
  51. YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer
    Cheukfai Li, Chuanzhao Zhang, Guochun Zhang, Bo Chen, Xuerui Li, Kai Li, Chongyang Ren, Lingzhu Wen, Ning Liao · 2022 · Cancer Biomarkers
  52. Identification of Implications of Angiogenesis and m6A Modification on Immunosuppression and Therapeutic Sensitivity in Low-Grade Glioma by Network Computational Analysis of Subtypes and Signatures
    Bo Li, Fang Wang, Nan Wang, Kuiyuan Hou, Jianyang Du · 2022 · Frontiers in Immunology
  53. m6A modification: a new avenue for anti-cancer therapy
    Yongtai Bai, Kai Li, Jinying Peng, Chengqi Yi · 2023 · Life Medicine
  54. Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations
    Jing Zhang, Jingjing Jiang, Yu Luo, Xiaomu Li, Zhiqiang Lu, Yujun Liu, Jie Huang, Yingyong Hou, Ying Ki Pang, Mitchell Sun et al. · 2018 · Endocrine
  55. Combating cancer stem cells: RNA m6A methylation and small-molecule drug discovery
    Honghai Zhang, Xueer Wang, Jianjun Chen, Rui Jun Su · 2024 · Frontiers in Drug Discovery
  56. Targeting m6A RNA Modification in Tumor Therapeutics
    Zhenwei Mao, Min Li, Shengjun Wang · 2025 · Current Oncology
  57. Exploring Site-Specific N6-Methyladenosine Modifications as New Cancer Biomarkers via SERS-Based Single-Cell Assay and Histopathological Imaging
    Sijia Sun, Dan Xie, Wenyan Guan, Qi Li, Jian He, Ying Li, Jingran Chen, Song Wei Gao, Zhen Liu · 2025 · Analytical Chemistry
  58. Meta-unstable mRNAs in activated CD8+ T cells are defined by interlinked AU-rich elements and m6A mRNA methylation
    Paulo A. Gameiro, Iosifina P. Foskolou, Yumna A. Butt, Aniek Martens, Klara Kuret, Igor Ruiz de los Mozos, Nordin D. Zandhuis, Žan Hozjan, Veronica Kot, Rupert Faraway et al. · 2026 · Nature Communications
  59. m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia
    Zi‐jun Xu, Xiang-mei Wen, Yuan-cui Zhang, Ye Jin, Ji‐chun Ma, Yu Gu, Xinyi Chen, Pei‐hui Xia, Wei Qian, Jiang Lin et al. · 2022 · Frontiers in Genetics
  60. SomaticIDH1Hotspot Variants in Chinese Patients With Pheochromocytomas and Paragangliomas
    Minghao Li, Yazhi He, Yingxian Pang, Jing Zhang, Yu Ying Feng, Yao He, Xiaowen Xu, Yongbao Wei, Dewen Zhong, Wanglong Deng et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  61. Delivery of PARP inhibitors through 2HG-incorporated liposomes for synergistically targeting DNA repair in cancer
    Zhangyi Luo, Yixian Huang, Shangyu Chen, Bei Zhang, Haozhe Huang, Sheida Dabiri, Yuang Chen, Anju Zhang, Alexis R. Andreas, Song Li · 2024 · Cancer Letters
  62. The diverse landscape of RNA modifications in cancer development and progression
    Hyung Seok Kim, Jung Woo Eun, Seonghoe Jang, Ji Yun Kim, Jee‐Yeong Jeong · 2024 · Genes & Genomics
  63. Expression pattern of alkB homolog 5 in goat testis and its role in spermatogonial stem cells
    Zifei Liu, Yu Cai, Mingtian Deng, Dongxu Li, Qingqing Leng, Liangyue Shi, Yutong Tang, Feng Wang, Yongjie Wan · 2021 · Cell and Tissue Research
  64. Comparative study of the binding between chlorogenic acid and four proteins by isothermal titration calorimetry, spectroscopy and docking methods
    Miao Zhang, Ning Zhang, Xinluan Lu, Wenjin Li, Ruiyong Wang, Junbiao Chang · 2022 · Pharmacological Reports
  65. RNA m6A modification: Mapping methods, roles, and mechanisms in acute myeloid leukemia
    Rong Yin, Yashu Li, Wen Tian, Fuling Zhou, Haojian Zhang · 2022 · Blood Science
  66. Circ‐N4BP2L2 enhances mitochondrial function in non‐small cell lung cancer cells through regulating the miR ‐135a‐5p/ ARL5B axis
    Hongyang Shi, Yuqiang Ji, Yonghong Zhang, Yu Wang, Wei Li · 2023 · Environmental Toxicology
  67. Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics
    Ágota Tűzesi, Susannah M. Hallal, Laveniya Satgunaseelan, Michael E. Buckland, Kimberley L. Alexander · 2023 · Cancers
  68. Defining the functions of adenosine-to-inosine RNA editing through hematology
    Jacki E. Heraud-Farlow, Alistair M. Chalk, Carl R. Walkley · 2019 · Current Opinion in Hematology
  69. Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and Lymphoma
    Maximilian F. Stahl, Zachary Drew Epstein-Peterson, Andrew M. Intlekofer · 2020 · Cold Spring Harbor Perspectives in Medicine
  70. Targeting FTO for cancer therapy and more
    Ying Qing, Rui Jun Su, Jianjun Chen · 2021 · Aging
  71. Unveiling the role of RNA methylation in glioma: Mechanisms, prognostic biomarkers, and therapeutic targets
    Qichen Xu, Chunsong Yang, Liyun Wang, Jing Zhou · 2024 · Cellular Signalling
  72. Interplay between epigenetics and metabolism controls cancer stem cell plasticity
    Jee-Eun Choi, Inwha Baek · 2024 · Frontiers in Epigenetics and Epigenomics
  73. Single-cell transcriptome profiling of m6A regulator-mediated methylation modification patterns in elderly acute myeloid leukemia patients
    Zhe Wang, Xin Du, Peidong Zhang, Meiling Zhao, Tianbo Zhang, Jiang Liu, Xiaolan Wang, Doudou Chang, Xiaxia Liu, Sicheng Bian et al. · 2024 · Molecular Biomedicine
  74. Epigenetic regulation in oogenesis and fetal development: insights into m6A modifications
    Lusheng Liu, Danxia Ge, Yumeng Lin, Zhongyu Han, Heng Zhao, Liqin Cao, Xi Wu, Guizhi Ma · 2025 · Frontiers in Immunology
  75. Quantification of Epigenetic DNA and RNA Modifications by UHPLC–MS/MS Technologies: New Concepts and New Improvements for the Special Collections
    Rui Zhang, Hailong Liu, Biao Bai, Hailin Wang · 2025 · Journal of Separation Science
  76. N6-methyladenosine reader YTHDF3-mediated CEBPA translation maintains genomic stability and stem cell function to prevent liver injury
    Yaxu Liang, Weiwei Yu, Haifeng Sun, Dayu Wang, Zhibo Wang, Hailing Shi, Yang Cao, Zijie Scott Zhang, Jun Liu, Zhongyu Zou et al. · 2025 · Science China Life Sciences
  77. Development of Orally Bioavailable FTO Inhibitors with Potent Antileukemia Efficacy.
    Teng Yang, Ze Dong, Rong Du, Yiqing Wang, Lu Liu, Yangyang Xue, Xi Zhang, Yong-Gang Liao, J. Gan, Xiao-Xuan Yu et al. · 2025 · Journal of Medicinal Chemistry
  78. m1A methylase TRMT6 promotes neuroblastoma development by demethylating SST mRNA in an m1A/YTHDF2-dependent manner
    Xinxin Zhang, Huiran Lin, Huimin Yin, Yufeng Han, Liping Chen, Mengzhen Zhang, Hongxia Chen, Jing He, Zhenjian Zhuo · 2025 · British Journal of Cancer
  79. m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis
    Zhen Tan, Jianhui Yang, Yueyue Chen, Heng Zhu, Xiaomeng Liu, Xu He, Qingcai Meng, Mingming Xiao, Rong Tang, Zeyin Rong et al. · 2025 · Cell Death and Disease
  80. N6-Methyladenosine RNA Modification in Normal and Malignant Hematopoiesis
    Hengyou Weng, Huilin Huang, Jianjun Chen · 2023 · Advances in experimental medicine and biology
  81. FTO-mediated regulation of m6A methylation is closely related to apoptosis induced by repeated UV irradiation
    Yao Lin, Yu Sun, Wenyi Hou, Xinling Chen, Feng Zhou, Qingfang Xu, Yue Zheng · 2024 · Journal of Dermatological Science
  82. Current insights on m6A RNA modification in acute leukemia: therapeutic targets and future prospects
    Parminder Kaur, Pankaj Sharma, Prateek Bhatia, Minu Singh · 2024 · Frontiers in Oncology
  83. One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
    Antonia Kalushkova, Patrick Nylund, Alba Atienza Párraga, Andreas Lennartsson, Helena Jernberg‐Wiklund · 2021 · Epigenomes
  84. One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia
    Xianfeng Ouyang, Yuping Gong · 2022 · Frontiers in Immunology
  85. Potential Impact of N6-Methyladenosine RNA Methylation on Vision Function and the Pathological Processes of Ocular Diseases: New Discoveries and Future Perspectives
    Xiaohua Li, Binyun Ma, Mengyu Liao, Lingke Li, Xiaodan Zhang, Mei Du, Jinguo Yu, Shikun He, Hua Yan · 2022 · Frontiers in Bioscience-Landmark
  86. Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
    Jiahua Chen, Bao Guo, Xiaojing Liu, Jing Zhang, Junhui Zhang, Yuan Fang, Suding Zhu, Bing Wei, Yunxia Cao, Lei Zhan · 2022 · Experimental Hematology and Oncology
  87. Comprehensive analysis of the prognostic impact and immune implication of KIAA1429 in lung adenocarcinoma
    Lei Guo, Qilin Huai, Bolun Zhou, Jianming Ying, Wei Guo · 2022 · Cancer Innovation
  88. SCARPET: site-specific quantification of methylated and nonmethylated adenosines reveals m6A stoichiometry
    Aashiq Hussain Mirza, Yaron Bram, Robert E. Schwartz, Samie R. Jaffrey · 2023 · RNA
  89. The role of chlorine atom on the binding between 2‐phenyl‐1H‐benzimidazole analogues and fat mass and obesity‐associated protein
    Junya Li, Ying Wang, Xinxin Han, Ning Wang, Wenquan Yu, Ruiyong Wang, Junbiao Chang · 2018 · Journal of Molecular Recognition
  90. RNA m6A Modification Plays a Key Role in Maintaining Stem Cell Function in Normal and Malignant Hematopoiesis
    Peipei Wang, Mengdie Feng, Guoqiang Han, Rong Yin, Yashu Li, Shuxin Yao, Pengbo Lu, Yuhua Wang, Haojian Zhang · 2021 · Frontiers in Cell and Developmental Biology
  91. Passive shaping of intra- and intercellular m6A dynamics via mRNA metabolism
    David Dierks, Ran Shachar, Ronit Nir, Miguel Angel García-Campos, Anna Uzonyi, David Wiener, Ursula Toth, Walter Rossmanith, Lior Lasman, Boris Slobodin et al. · 2024 · eLife
  92. N6-methyladenosine and its epitranscriptomic effects on hematopoietic stem cell regulation and leukemogenesis
    Kao-Jung Chang, Li-Yang Shiau, Shiuan-Chen Lin, Han-Ping Cheong, Ching‐Yun Wang, Chun Ma, Yanwen Liang, Yiping Yang, Po‐Shen Ko, Chih-Hung Hsu et al. · 2024 · Molecular Medicine
  93. Discovery of the 2,3-Dihydrobenzopyrane-4-one as a Potent FTO Inhibitor against Obesity-Related Metabolic Diseases
    Duo Ma, Xianan Liu, Xingxing Zhang, Yaling Hong, Yumeng Wang, Famin Zhang, Leran Du, Junjie Zhao, Quan Wang, Cui Chang et al. · 2025 · Journal of Medicinal Chemistry
  94. UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
    Fengqi Zhou, Yuanyuan Sun, Xinhua Chen, Di Wu, Zhennan Tao, Lingyun Wu, Gao Chen, Xiangyu Liu, Tianfu Yu · 2025 · Clinical Cancer Research
  95. m6A-driven transcriptomic rewiring in tumor immune surveillance
    Parmanand Malvi, Patricia M. Ball, Romi Gupta, Narendra Wajapeyee · 2025 · Journal for ImmunoTherapy of Cancer
  96. Regulation of RNA-binding proteins by small biomolecules
    Weili Miao, Douglas F. Porter, Vanessa Lopez-Pajares, Paul A. Khavari · 2025 · Nature Reviews Molecular Cell Biology
  97. Mitochondria at the intersections of RNA modifications and metabolism reprogramming implications in cell death, tumor microenvironment, and immunotherapy
    Jiaxun Zhang, Haoxuan Zhang, Leifeng Chen, Yuze Wu, Jiaming Xie, Yannan Yang, Aaron Chen, Akezhouli Shahatiaili, Shan Muhammad, Wenhui Yang et al. · 2025 · Journal of Hematology & Oncology
  98. RNA modifications in gynecological cancer: current status and future directions
    Wanshan He, Xiaoshan Hong, Guanqiao Chen, Xiping Luo, Yu Lin · 2024 · Frontiers in Medicine
  99. Internal m6A and m7G RNA modifications in hematopoietic system and acute myeloid leukemia
    Xiaoxu Zhang, Yanni Ma, Jia Yu, Rui Jun Su, Xiaoshuang Wang · 2024 · Chinese Medical Journal
  100. m6A methyltransferase AflIme4 orchestrates mycelial growth, development and aflatoxin B1 biosynthesis in Aspergillus flavus
    Liuke Liang, Xiaoyan Wang, Shan Wei, Lei Yang, Shuaibing Zhang, Huan-Chen Zhai, Yuansen Hu, Yangyong Lv · 2024 · Microbiological Research